Antisense oligonucleotide mediated therapy of spinal muscular atrophy

Articles in the same Issue

1. Antisense oligonucleotide mediated therapy of spinal muscular atrophy
2. Region-specific neuron and synapse loss in the hippocampus of APPSL/PS1 knock-in mice
3. Using transcranial electrical stimulation to enhance cognitive functions in the typical and atypical brain
4. The olfactory system in Alzheimer’s disease: Pathology, pathophysiology and pathway for therapy
5. The role of neurotrophins in major depressive disorder
6. Diffusion MR imaging: How to get the maximum from the experimental time
7. G protein co-signaling and challenges for translational research
8. Targeting the somatostatin receptors as a therapeutic approach for the preservation and protection of the mammalian cochlea from excitotoxicity
9. Reassessment of teratogenic risk from antenatal ultrasound
10. Cognitive findings in childhood anxiety: Translations for clinical practice
11. Neuropsychological rehabilitation for bipolar disorder — A single case design
12. The renaissance of the neuron doctrine: Cajal rebuts the Rector of Granada